SecBot SecBot
SECBOTREPLAY Home › Report › NRIX

NRIX · Two C-suite insiders at Nurix Therapeutics sold a combined $107K in…

Nurix Therapeutics, Inc. · CLUSTER filed Apr 30, 2026 at 17:38 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Apr 30, 2026 at 17:38 ET

Two C-suite insiders at Nurix Therapeutics sold a combined $107K in open-market shares on April 30, 2026, following derivative exercises at $0 cost. The sales are routine tax-related dispositions tied to option exercises and represent only ~0.006% of the $1.7B market cap, making them immaterial.

  • Chief Scientific Officer Gwenn Hansen sold 3,214 shares at $16.65 for $53K on April 30, 2026
  • Chief Legal Officer Christine Ring sold 3,214 shares at $16.65 for $53K on April 30, 2026
  • Both insiders simultaneously exercised 2,000 options each at $0 exercise price (non-cash events)
  • Total open-market sales of $107K represent ~0.006% of NRIX's $1.7B market cap

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access